Industrial Chain Advantage
The comprehensive strength and multiple advantages of CR will bring long-term healthy development capability and collaborative innovation value for CR Healthcare to be involved in the reform of Chinese medical system.
CR Group
China Resources (Holdings) Co., Ltd. is one of the key state-owned enterprises directly under the supervision and leadership of the SASAC (State-owned Assets Supervision and Administration Commission of the State Council); its main businesses include consumer goods, electric power, real estate, cement, gas, pharmaceuticals and healthcare, and finance, etc. With the mission of "lead the business progress, create a better life",CR innovats business model, builds brand products and services, and effectively promots the development of industries and public's life quality.At present, CR’s retail business, Snow beer brand and gas operations are the largest of their kind in China. CR Power is an independent power generation enterprise with the highest earnings growth, lowest operating cost, and highest operational efficiency in China. CR Land is one of the most reputable and integrated real estate developers in mainland China, while “Snow” beer, “C’estbon” purified water, “CR Vanguard” supermarkets, and the “MIXC” mall are all household brands in China.In 2016,CR realized sales revenue of rmb503.4bn, with a total profit of rmb48.3 billion and total assets of rmb110,000bn.
CR Pharmceutical
CR Pharmceutical is China's leading integrated pharmaceutical company, which is engaged in the R&D, manufacturing, distribution and retail a wide variety of medical and other nutritional health products.It is the second largest pharmaceutical manufacturers, China's second largest pharmaceutical distributors. In 2016, CR pharmaceutical sales revenue reached hk $156.7 billion, and the operating profit was hk $9 billion.CR Pharmceutical’s pharmaceutical business covers chemical medicine, traditional Chinese medicine, biological agents and nutrition health care products, products cover a series of good growth potential therapeutic areas,such as cardiovascular system, cold cough, anti-infection, reproductive health, the digestive tract and metabolism, skin and pediatrics. CR pharmaceutical is a leading medical supply chain solution provider in China, has a national network coverage of the leading pharmaceutical distribution and retail platform, which can privide highly professional and efficient pharmaceutical logistics distribution, marketing, and other innovative value-added services for nearly thousands of upstream suppliers and nearly 70,000 downstream clients.
CR Land
CR Land is one of the most powerful comprehensive real estate developers in mainland China. Its main businesses include real estate development, commercial real estate development and operation, property service and so on. By the end of 2016, there were more than 30,000 employees in the company, with total assets of 427 billion Hong Kong dollars. The land reserve area was 4,485 million square meters, and it was stationed in 57 cities in China, with over 150 development projects. During the "13th Five-Year" period, CR Land established business model that called "property sales + investment property + X" , namely based on continuing to adhere to the two main businesses of selling property and investment properties,actively broaden the business development model,such as shopping mall + Internet ecosystem construction,property services, senior real estate and overseas real estate,etc..In the future, CR Land will foster new value growth points through its strategic initiatives of "precision investment, operational excellence, innovation and innovation" and committs to becoming the leading integrated real estate enterprise in the industry.
CR Capital
China Resources Capital Holdings Company Limited (CR Capital) has CR Bank, CR Trust, CR Asset and Harvest Capital under it, with strategic holdings of Guosen Securities, Penghua Fund, Huatai Insurance and other domestic financial institutions, as well as CR Yuanda Fund jointly set up with Taiwan Yuanda. CR Capital, supported by diversified industrial base of the CR Group, is committed to becoming a leading integrated financial service platform with unique Chinese characteristics through the business model that combines industry and finance with cooperation between financial institutions. Its businesses involve banking, trusts, funds and other fields, providing customers with comprehensive financial solutions, bringing more smart assets, more valuable wealth, and contributing more fortune and intelligence to people’s happy life.
CR Enterprise
CR Enterprise is CR’s flagship listed companies in Hong Kong specializing in retail and consumer goods business; it is also a constituent stock of the Hang Seng Index. Main business includes beer, food and drinks three plates.It is committed to become a world-class consumer goods and retail services company. Beer Business - China Resources Brewery (Holdings) Limited is listed on the Stock Exchange of Hong Kong Limited (stock code: 00291); its subsidiary, China Resources Snow Breweries Limited is the largest beer production and marketing area in the PRC, with Snowflake since 2008 Become the world's highest single-brand sales. Food Business - CR Ng Fung is an excellent integrated food enterprise group, which integrates food research and development, production, processing, wholesale, retail, transportation and international trade. It owns multiple famous brands, such as Ng Fung, Man Tai Ji, Xi Shang Xi,and etc.. Food Business - China Resources Cestbon Beverage (China) Co., Ltd. is one of the leading beverage companies in China with many brands including "CIBA" and "Afternoon Tea" and etc.. Its product categories include pure water, milk tea, etc., with a 30 SKU.
Contact Us |  Site Map |  Disclaimer |  Privacy Policy
Copyright © China Resources CR Healthcare Company Limited. Technical Support : CR CR Healthcare Information Management Dept.